[PDF][PDF] SMOC-2 suppression in Diffuse Large B-Cell Lymphoma may confer resistance to rituximab

D Binda - 2018 - ecommons.cornell.edu
Rituximab is a genetically constructed chimeric mouse-human monoclonal IgG1 kappa
antibody that recognizes the CD20 antigen. It has been the top selling oncology drug for …